The acquisition of the majority stake in Bayshore by Ipca Labs#39; wholly-owned subsidiary will enable the company to commercialise its registered generics drug products in the US market through this entity, Ipca Laboratories said in a regulatory filing.Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for $10.28 mn
The acquisition of the majority stake in Bayshore by Ipca Labs#39; wholly-owned subsidiary will enable the company to commercialise its registered generics drug products in the US market through this entity, Ipca Laboratories said in a regulatory filing.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
-
"Paytm is now empowering feature phone users to recharge for their Vodafone Idea numbers with just a valid UPI ID. Along with the tele...
No comments:
Post a Comment